Company profile

Persyst Development Corporation

Persyst Development Corporation has 1 AI-enabled medical device on the FDA list. The first decision was on November 29, 2018 and the most recent on November 29, 2018 (Persyst 14 EEG Review and Analysis Software). Its most common review panel is Neurology (1 device).

1AI devices

2018First decision

2018Latest decision

1Specialties

Timeline

November 29, 2018 · 510(k) K182181Persyst 14 EEG Review and Analysis Software · Neurology · OMB